Misonix, Inc. (NASDAQ: MSON) has their efforts focused on designing, developing, and manufacturing one of the broadest ranges of Therapeutic Ultrasonic Medical Devices. The company’s aim is to develop products that will improve patients’ quality of life by incorporating the highest level of quality and innovation into each and every product. Current application of their technology ranges from kidney stone pulverization and the aspiration of brain tumors to the latest technological breakthrough HIFU (High Intensity Focused Ultrasound) for various cancer treatments. For further information, visit the Company’s web site at www.misonix.com.
- 18 years ago
QualityStocks
Misonix, Inc. (NASDAQ: MSON)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones
Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory…
-
Wrap Technologies Inc. (NASDAQ: WRAP) Positions Non-Lethal Innovation at the Center of Public Safety Reform
WRAP offerings illustrate a broader industry trend toward building connected ecosystems rather than standalone products.…
-
Brownfield Gold Projects Could Hold an Edge in Today’s Permitting Environment
Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.…